Studies related to Viral Load and Colostrum

Intensification Of Antiretroviral Therapy With Raltegravir Or Addition Of Hyperimmune Bovine Colostrum In HIV-infected Patients With Suboptimal CD4+ T-cell Response: A Randomized Controlled Trial

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 73
Sex Both Genders
Age Range 45-64
Notes for this study:
Supplementation of 1,200mg colostrum (40% immunoglobulins) daily for 24 weeks in HIV infected persons on stable antiretroviral therapy (known to decrease CD4+ lymphocytes) failed to improve the suppressed lymphocytes relative to control. Serum HIV-RNA was also not affected by therapy.